Compare RYM & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYM | ZTEK |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Canada |
| Employees | 141 | N/A |
| Industry | Farming/Seeds/Milling | Major Chemicals |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 68.8M |
| IPO Year | N/A | 2022 |
| Metric | RYM | ZTEK |
|---|---|---|
| Price | $24.72 | $0.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.5K | ★ 188.8K |
| Earning Date | 05-12-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.00 | $0.40 |
| 52 Week High | $53.65 | $1.55 |
| Indicator | RYM | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 43.91 |
| Support Level | $24.33 | $0.43 |
| Resistance Level | $30.35 | $0.75 |
| Average True Range (ATR) | 1.51 | 0.08 |
| MACD | -0.41 | -0.03 |
| Stochastic Oscillator | 9.93 | 3.38 |
Rythm Inc is a USA Based company. The company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.